Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes.

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...

Yale operates first the BATMAN procedure in CT, a less invasive heart treatment offering faster recovery and new hope for ...

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Mitral Valve Regurgitation: The valve doesn’t close completely, allowing blood to leak backward into the atrium. Mitral Valve Stenosis: The valve becomes too narrow, restricting proper blood flow.

He reported that both patients who underwent the procedure had their mitral regurgitation eliminated ... is to ‘transform the treatment of structural heart disease'. Mitral valve replacement is its ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...